|
Year
|
Positive anti-HEV IgG/Total (%)
|
Chi square test, P-value
|
|---|
|
Male
|
Female
|
|---|
|
2015
|
47/68 (69.12)
|
44/70 (62.86)
|
0.602, p = 0.438
|
|
2016
|
55/111 (49.55)
|
44/91 (48.35)
|
0.029, p = 0.865
|
|
2017
|
57/131 (43.51)
|
47/145 (32.41)
|
3.610, p = 0.057
|
|
2018
|
46/145 (31.72)
|
29/143 (20.28)
|
4.896, p = 0.027*
|
|
Total
|
205/455 (45.05)
|
164/449 (36.53)
|
6.806, p = 0.009*
|
- Numbers of positive anti-HEV IgG serum samples/total samples in male and female patients were demonstrated in percentages per year (2015–2018). Chi-square test was used to analyze the association between gender and anti-HEV IgG seropositivity. A P-value less than 0.05 is considered statistical significance
